Tuesday, April 28, 2020

Denovo Biopharma Acquires Tocagen's Replicating Gene Therapy Platform

San Diego-based Denovo Biopharma said this morning that it has acquired the entire replicating gene therapy platform from Tocagen. Financial details of the acquisition were not announced. Denovo Biopharma said it acquired retroviral replicating vector platform (RRV) in its entirety, including its invest

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---